Daily Stock Setups

Asuragen signs development agreement with Life Technologies for BCR/ ABL1 assay

Posted on: Wed, 18 Nov 2009 13:16:00 EST

Symbols: LIFE

Do you know when to trade LIFE ?

Check for a PowerRating from TradingMarkets

Nov 18, 2009 (Datamonitor Financial Deals Tracker via COMTEX) --
LIFE | Quote | Chart | News | PowerRating -- Asuragen, Inc. has entered into an exclusive agreement with Life Technologies Corporation to develop and distribute BCR/ ABL1 assay, an in-vitro diagnostic test intended to aid clinicians in the monitoring and treatment of individuals afflicted with chronic myeloid leukemia (CML), worldwide. Asuragen is a RNA-based therapeutic and diagnostics company, while Life Technologies is a biotechnology tools company. Both the partners are based in the US.

Under the terms of the agreement, Asuragen will be responsible for CE marked-IVD registration in Europe and regulatory clearance in the US. The diagnostic test will then be distributed by Life Technologies and run exclusively on the Applied Biosystems 7,500 Fast Dx Real-Time PCR Instrument.

The BCR/ ABL1 assay will simultaneously detect and quantify BCR/ABL1 fusion transcripts (b2a2, b3a2, and e1a2) in a single reaction. The BCR-ABL1 fusion gene arises from a specific chromosome translocation, known as the Philadelphia chromosome or t(9:22).

Deal Type    Partnership
Sub-Category Development,Acquisition of Rights,Distribution
Deal Status  Announced: 2009-11-18

Deal Participants

Partner 1 (Company) Life Technologies Corporation (formerly Invitrogen Corporation)
Partner 2 (Company) Asuragen, Inc.

For full details on Life Technologies Corporation (LIFE) LIFE. Life Technologies Corporation (LIFE) has Short Term PowerRatings at TradingMarkets. Details on Life Technologies Corporation (LIFE) Short Term PowerRatings is available at This Link.

More News: Market Updates | Stock Alerts | All Trading News

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.